RxDoctor Payments Data

Christopher Roberts

Urogynecology and Reconstructive Pelvic Surgery · Joplin, MONPI 1609936293

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 44.2% of the total. Reporting peaked in 2020 at $422 and has fallen 84.8% since, to $64 in 2025. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in MO, where the typical reported total is $2,496.

$2,156in general payments, 2019–2025

Across 149 payments — averaging $14.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$954
  • AbbVie$271
  • Novo Nordisk$183
  • Lilly USA, LLC$163
  • Antares Pharma, Inc.$144
  • Amgen$123
  • plus $319 from 8 others

What the payments were for

  • Food & beverage$2,149100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,156 in reported general payments places this provider in the 45th percentile of 21 urogynecology and reconstructive pelvic surgery providers in Missouri.

See all urogynecology and reconstructive pelvic surgery providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide32$33,597
TrulicityDulaglutide15$12,183
MyrbetriqMirabegron16$10,773
Liothyronine Sodium130$3,177
Estradiol (Twice Weekly)Estradiol24$1,994
ProgesteroneProgesterone, Micronized74$1,820
DottiEstradiol18$1,400
Np ThyroidThyroid,pork37$1,230
Cimetidine26$1,141
Armour ThyroidThyroid,pork19$804
Ezetimibe112$656
Levothyroxine Sodium69$359
Doxepin Hcl14$106
Metformin Hcl ErMetformin Hcl34$97
Estradiol23$75

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$163$45,78047 claims
Astellas Pharma US IncMyrbetriq$17$10,77316 claims
Acella Pharmaceuticals, LLCNp Thyroid$44$1,23037 claims
AbbVieArmour Thyroid$271$80419 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 21 urogynecology and reconstructive pelvic surgery providers in Missouri.

Other urogynecology and reconstructive pelvic surgery in Joplin

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →